This invention provides a novel crystalline form of phenelzine
optically active intermediate IIa and its preparation method. The
powder X-
ray diffraction pattern of this novel crystalline form has the following characteristic
diffraction angles: 8.89°, 12.78°, 19.33°, 21.43°, 22.05°, 26.77°, and 27.01°, with an error range of ±0.2° for the
diffraction angle 2θ values. This invention also provides a method for preparing this novel crystalline form and its pharmaceutical applications, including its use in the preparation of phenelzine, and even its use as a chiral resolving agent in the preparation of phenelzine.